Integrin expression and function in the response of primary culture hepatic stellate cells to connective tissue growth factor (CCN2)

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 5, 2011, Pages 1087-1095

  Huang, Guangcun ^a   Brigstock, David R ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

CCN2; Cell adhesion; Connective tissue growth factor; Fibronectin; Hepatic stellate cells; Integrin

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CTGF PROTEIN, MOUSE; DRUG DERIVATIVE; FIBRONECTIN; HEPARIN; HEPARIN PROTEOGLYCAN; PROTEOGLYCAN; SMALL INTERFERING RNA; VERY LATE ACTIVATION ANTIGEN 5;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL ADHESION; CELL CULTURE; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; LIVER CIRRHOSIS; METABOLISM; MOUSE; PATHOPHYSIOLOGY; RNA INTERFERENCE; STELLATE CELL;

ANIMALS; CELL ADHESION; CELLS, CULTURED; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; HEPARIN; HEPATIC STELLATE CELLS; INTEGRIN ALPHA5BETA1; LIVER CIRRHOSIS; MICE; MICE, INBRED BALB C; PROTEOGLYCANS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

MUS;

EID: 79957582013     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01072.x     Document Type: Article

References (39)

1. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008; 134: 1655-69.
2. Iredale J. Defining therapeutic targets for liver fibrosis: exploiting the biology of inflammation and repair. Pharmacol Res. 2008; 58: 129-36.
3. Friedman SL. Stellate cells: a moving target in hepatic fibrogenesis. Hepatology. 2004; 40: 1041-3.
4. Reeves HL, Friedman SL. Activation of hepatic stellate cells-a key issue in liver fibrosis. Front Biosci. 2002; 7: d808-26.
5. Rachfal AW, Brigstock DR. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res. 2003; 26: 1-9.
6. Shi-Wen X, Leask A, Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 2008; 19: 133-44.
7. Cicha I, Goppelt-Struebe M. Connective tissue growth factor: context-dependent functions and mechanisms of regulation. Biofactors. 2009; 35: 200-8.
8. George J, Tsutsumi M. siRNA-mediated knockdown of connective tissue growth factor preventsN-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther. 2007; 14: 790-803.
9. Li G, Li D, Xie Q, et al RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production. J Gene Med. 2008; 10: 1039-47.
10. Paradis V, Dargere D, Bonvoust F, et al Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest. 2002; 82: 767-74.
11. Uchio K, Graham M, Dean NM, et al Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis. Wound Repair Regen. 2004; 12: 60-6.
12. Williams EJ, Gaca MD, Brigstock DR, et al Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. J Hepatol. 2000; 32: 754-61.
13. Yuhua Z, Wanhua R, Chenggang S, et al Disruption of connective tissue growth factor by short hairpin RNA inhibits collagen synthesis and extracellular matrix secretion in hepatic stellate cells. Liver Int. 2008; 28: 632-9.
14. Gao R, Ball DK, Perbal B, et al Connective tissue growth factor induces c-fos gene activation and cell proliferation through p44/42 MAP kinase in primary rat hepatic stellate cells. J Hepatol. 2004; 40: 431-8.
15. 3 and heparan sulfate proteoglycan. J Biol Chem. 2004; 279: 8848-55.
16. Gao R, Brigstock DR. Activation of nuclear factor kappa B (NF-κB) by connective tissue growth factor (CCN2) is involved in sustaining the survival of primary rat hepatic stellate cells. Cell Commun Signal. 2005; 3: 14.
17. 1 binding domain in module 4 of connective tissue growth factor (CCN2/CTGF) promotes adhesion and migration of activated pancreatic stellate cells. Gut. 2006; 55: 856-62.
18. 1 as a novel CCN2 receptor. Gastroenterology. 2005; 129: 1019-30.
19. Pi L, Ding X, Jorgensen M, et al Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activation. Hepatology. 2008; 47: 996-1004.
20. Ball DK, Moussad EE, Rageh MA, et al Establishment of a recombinant expression system for connective tissue growth factor (CTGF) that models CTGF processing in utero. Reproduction. 2003; 125: 271-84.
21. Ball DK, Rachfal AW, Kemper SA, et al The heparin-binding 10 kDa fragment of connective tissue growth factor (CTGF) containing module 4 alone stimulates cell adhesion. J Endocrinol. 2003; 176: R1-7.
22. Leask A, Chen S, Pala D, et al Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells. J Cell Commun Signal. 2008; 2: 49-56.
23. Lau LF, Lam SC. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res. 1999; 248: 44-57.
24. Chen Y, Abraham DJ, Shi-Wen X, et al CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell. 2004; 15: 5635-46.
25. Hoshijima M, Hattori T, Inoue M, et al CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin α5β1. FEBS Lett. 2006; 580: 1376-82.
26. 2 as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood. 2002; 99: 4457-65.
27. Weston BS, Wahab NA, Mason RM. CTGF mediates TGF-β-induced fibronectin matrix deposition by upregulating active α5β1integrin in human mesangial cells. J Am Soc Nephrol. 2003; 14: 601-10.
28. Tong ZY, Brigstock DR. Intrinsic biological activity of the thrombospondin structural homology repeat in connective tissue growth factor. J Endocrinol. 2006; 188: R1-8.
29. Brigstock DR. Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): from pharmacological inhibitionin vitroto targeted siRNA therapyin vivo. J Cell Commun Signal. 2009; 3: 5-18.
30. Tong Z, Chen R, Alt DS, et al Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes. Hepatology. 2009; 50: 939-47.
31. Brigstock DR, Steffen CL, Kim GY, et al Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulatedMr 10, 000 forms of connective tissue growth factor. J Biol Chem. 1997; 272: 20275-82.
32. Dodig M, Ogunwale B, Dasarathy S, et al Differences in regulation of type I collagen synthesis in primary and passaged hepatic stellate cell cultures: the role of alpha5beta1-integrin. Am J Physiol Gastrointest Liver Physiol. 2007; 293: G154-64.
33. Levine D, Rockey DC, Milner TA, et al Expression of the integrin α8β1during pulmonary and hepatic fibrosis. Am J Pathol. 2000; 156: 1927-35.
34. Quondamatteo F, Kempkensteffen C, Miosge N, et al Ultrastructural localization of integrin subunits α3 and α6 in capillarized sinusoids of the human cirrhotic liver. Histol Histopathol. 2004; 19: 799-806.
35. 3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem. 2004; 279: 23996-4006.
36. 1 of hepatic stellate cells in rat liver fibrosis. Chin Med J. 2000; 113: 272-76.
37. Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol. 2009; 41: 771-83.
38. 1 integrin) in hepatic stellate cells is independent of tyrosine phosphorylation. J Hepatol. 2003; 39: 32-7.
39. Droppelmann CA, Gutierrez J, Vial C, et al Matrix metalloproteinase-2-deficient fibroblasts exhibit an alteration in the fibrotic response to connective tissue growth factor/CCN2 because of an increase in the levels of endogenous fibronectin. J Biol Chem. 2009; 284: 13551-61.